Acquired resistance to TKIs in solid tumours: learning from lung cancer
The use of advanced molecular profiling to direct the use of targeted therapy, such as
tyrosine kinase inhibitors (TKIs) for patients with advanced-stage non-small-cell lung cancer …
tyrosine kinase inhibitors (TKIs) for patients with advanced-stage non-small-cell lung cancer …
[引用][C] Acquired resistance to TKIs in solid tumours: learning from lung cancer
DR Camidge, W Pao, LV Sequist - Nature Reviews Clinical Oncology, 2014 - cir.nii.ac.jp
Acquired resistance to TKIs in solid tumours: learning from lung cancer | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Acquired resistance to TKIs in solid tumours: learning from lung cancer.
DR Camidge, W Pao, LV Sequist - Nature reviews. Clinical …, 2014 - europepmc.org
The use of advanced molecular profiling to direct the use of targeted therapy, such as
tyrosine kinase inhibitors (TKIs) for patients with advanced-stage non-small-cell lung cancer …
tyrosine kinase inhibitors (TKIs) for patients with advanced-stage non-small-cell lung cancer …
Acquired resistance to TKIs in solid tumours: learning from lung cancer
DR Camidge, W Pao… - Nature reviews. Clinical …, 2014 - pubmed.ncbi.nlm.nih.gov
The use of advanced molecular profiling to direct the use of targeted therapy, such as
tyrosine kinase inhibitors (TKIs) for patients with advanced-stage non-small-cell lung cancer …
tyrosine kinase inhibitors (TKIs) for patients with advanced-stage non-small-cell lung cancer …